AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Lusix lost $65 million as lab-grown diamond prices plummeted
2
Intel ends car leasing program in latest cost-cut
3
Israel urged to dump ‘Hasbara’, instead pivoting to highlight its place in the world
4
Intel shutting down startup accelerator Ignite amid massive cuts
5
The Gili Ra’anan model: Questions emerging from Cyberstarts' remarkable success
More news

Biomed

8 stories about Biomed
תרופות זירת הבריאות

Entera Bio Gives Nasdaq IPO Another Shot

21.05.18|Dror Reich
This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq
default image

Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange

29.04.18|Racheli Bindman
Dually listed on Nasdaq and TASE, Opko first submitted a request to delist from the TASE in early April
חממת קנאביס

An Israeli Company Wants to Treat Tourette Syndrome With Cannabis

09.04.18|Lilach Baumer
Therapix Biosciences announced the successful completion of phase 2 clinical trial of its cannabinoid-based drug, conducted at Yale University Monday
נאסד"ק וול סטריט

For the Fourth Time, Entera Bio Tries for Nasdaq IPO

08.01.18|Dror Reich
The Jerusalem-based biomed company plans to raise $55 million, with Oppenheimer & Co. as the sole underwriter
default image

Biomed Company Protalix to Lay Off a Fifth of its Workforce

26.11.17|Dror Reich
The Israel-based NYSE American-listed company is currently undergoing a streamlining process
תרופות טבע גלולות תרופה

Entera Bio Files for Nasdaq IPO

12.11.17|Lilach Baumer
The clinical stage company develops treatments mostly for osteoporosis and bone disorders
קולפלנט דיו ביולוגי

Collplant Takes a Step Towards 3D Organ Printing

17.10.17|Lilach Baumer
The Israel-based company develops collagen-based biological ink for 3D organ printing
default image

IPO Hopeful Entera Bio Moves to Better Position

13.09.17|Dror Reich
Clinical-stage company Entera Bio develops pioneering technology for orphan disease hypoparathyroidism
Previous Articles